Aiosyn

Nijmegen, Gelderland, The Netherlands

https://www.aiosyn.org

Company profile

Aiosyn company profile

Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancer and CKD drug development studies for biopharma.

Business identity

Website: https://www.aiosyn.org
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 00011-00050 employees
Revenue range: $1K+
Founded: 2021-07-30

Headquarters

Headquarters: Nijmegen, Gelderland, The Netherlands
Postal code: 6525 EC
Country code: NL
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Seed
Funding rounds: 4
Total equity funding: $4.9M
Last funding: Seed / $2.8M / 2025-09-09
Last equity funding: Seed / $2.8M
Investors: 4
Lead investors: 2
Founders: 4
Articles: 12

Categories and groups

Artificial Intelligence (AI)Health Care Health Diagnostics Machine Learning Medical Device Pharmaceutical Artificial Intelligence (AI)Data and Analytics Health Care Science and Engineering Software

Founders and investors

Founders

David TellezJeroen van der LaakPatrick de BoerWouter Bulten

Lead investors

Health InnovationsLUMO labs

Investors

Health InnovationsLUMO labsOostNLTNO Ventures

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.